Eligo Bioscience is a pioneering biotechnology company with operations in Paris, Boston, and New York, specializing in precision medicines that target the microbiome. Recognized as a World Economic Forum Technology Pioneer, Eligo leverages expertise in synthetic biology, CRISPR, phages, and gene therapy to develop innovative therapeutic solutions.

‌